PubRank

Steffen Borrmann

Author PubWeight™ 68.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2014 11.87
2 Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 2012 4.37
3 Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans R Soc Trop Med Hyg 2004 3.52
4 Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Lancet 2008 3.31
5 Short report: Piloting paperless data entry for clinical research in Africa. Am J Trop Med Hyg 2005 2.85
6 Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One 2009 2.43
7 In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother 2009 2.36
8 Fosmidomycin for malaria. Lancet 2002 2.03
9 Chloroquine resistance before and after its withdrawal in Kenya. Malar J 2009 1.88
10 Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004 1.85
11 Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 2009 1.70
12 Assessment of volume depletion in children with malaria. PLoS Med 2004 1.51
13 Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg 2014 1.51
14 Fosmidomycin for the treatment of malaria. Parasitol Res 2002 1.40
15 Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2010 1.31
16 Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PLoS One 2009 1.31
17 Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya. PLoS One 2010 1.30
18 Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Malar J 2013 1.21
19 Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis 2005 1.18
20 In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya. Antimicrob Agents Chemother 2010 1.15
21 Clinical and parasitological characteristics of puerperal malaria. J Infect Dis 2005 1.15
22 Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assay. PLoS One 2011 1.13
23 Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malaria. J Infect Dis 2003 1.11
24 In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa. J Infect Dis 2009 1.08
25 NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections. J Infect Dis 2012 1.04
26 In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation. Antimicrob Agents Chemother 2009 1.04
27 The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med 2015 0.99
28 Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 2011 0.98
29 PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation. J Infect Dis 2013 0.97
30 Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro. Int J Parasitol 2006 0.93
31 Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malar J 2015 0.91
32 Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses. J Infect Dis 2002 0.87
33 Arrested Plasmodium liver stages as experimental anti-malaria vaccines. Hum Vaccin 2011 0.85
34 Age-dependent enhancement of IFN-gamma responses to Plasmodium falciparum liver stage antigen-1 T cell epitopes. Parasitol Res 2002 0.82
35 Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism. Am J Physiol Regul Integr Comp Physiol 2010 0.81
36 Temporal association of acute hepatitis A and Plasmodium falciparum malaria in children. PLoS One 2011 0.80
37 Lack of multiple copies of pfmdr1 gene in Papua New Guinea. Trans R Soc Trop Med Hyg 2008 0.80
38 Severe malaria in a splenectomised Gabonese woman. Wien Klin Wochenschr 2003 0.79
39 Severe malarial anemia associated with increased soluble Fas ligand (sFasL) concentrations in Gabonese children. Eur Cytokine Netw 2004 0.78
40 Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother 2011 0.78
41 Antimalarial activity of isoquine against Kenyan Plasmodium falciparum clinical isolates and association with polymorphisms in pfcrt and pfmdr1 genes. J Antimicrob Chemother 2012 0.77
42 On blood examinations in East African malaria diseases. J Mol Med (Berl) 2002 0.75